{"id":"https://openalex.org/W1994797642","doi":"https://doi.org/10.1038/leu.2012.73","title":"Retention of CD34+ CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR\u2013ABL inhibitors","display_name":"Retention of CD34+ CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR\u2013ABL inhibitors","publication_year":2012,"publication_date":"2012-03-19","ids":{"openalex":"https://openalex.org/W1994797642","doi":"https://doi.org/10.1038/leu.2012.73","mag":"1994797642","pmid":"https://pubmed.ncbi.nlm.nih.gov/22425893","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3437405"},"language":"en","primary_location":{"id":"doi:10.1038/leu.2012.73","doi":"https://doi.org/10.1038/leu.2012.73","is_oa":true,"landing_page_url":"https://doi.org/10.1038/leu.2012.73","pdf_url":"https://www.nature.com/articles/leu201273.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/leu201273.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069675532","display_name":"Yosuke Minami","orcid":"https://orcid.org/0000-0003-0863-0739","observed_orcids":["https://orcid.org/0000-0003-0863-0739"]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Y Minami","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","Dept. of Hematology and Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Dept. of Hematology and Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A Abe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145673806","display_name":"Fujita Health University","ror":"https://ror.org/046f6cx68","country_code":"JP","type":"education","lineage":["https://openalex.org/I145673806"]},{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"A Abe","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","Department of Hematology, Fujita Health University, Toyoake, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Department of Hematology, Fujita Health University, Toyoake, Japan","institution_ids":["https://openalex.org/I145673806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008097340","display_name":"Miho Minami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M Minami","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","Dept. of Hematology and Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Dept. of Hematology and Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039102402","display_name":"KOUICHI KITAMURA","orcid":"https://orcid.org/0000-0001-9692-8724","observed_orcids":["https://orcid.org/0000-0001-9692-8724"]},"institutions":[{"id":"https://openalex.org/I4210113086","display_name":"Ichinomiya Municipal City Hospital","ror":"https://ror.org/026a4qe69","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210113086"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Kitamura","raw_affiliation_strings":["Department of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan","institution_ids":["https://openalex.org/I4210113086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044099774","display_name":"Junji Hiraga","orcid":"https://orcid.org/0000-0002-1845-4786","observed_orcids":["https://orcid.org/0000-0002-1845-4786"]},"institutions":[{"id":"https://openalex.org/I4210092859","display_name":"Toyota Memorial Hospital","ror":"https://ror.org/00hcz6468","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210092859"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"J Hiraga","raw_affiliation_strings":["Department of Hematology, Toyota Memorial Hospital, Toyota, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Toyota Memorial Hospital, Toyota, Japan","institution_ids":["https://openalex.org/I4210092859"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087651102","display_name":"Shinichi Mizuno","orcid":"https://orcid.org/0000-0002-0960-5036","observed_orcids":["https://orcid.org/0000-0002-0960-5036"]},"institutions":[{"id":"https://openalex.org/I4210092859","display_name":"Toyota Memorial Hospital","ror":"https://ror.org/00hcz6468","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210092859"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S Mizuno","raw_affiliation_strings":["Department of Hematology, Toyota Memorial Hospital, Toyota, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Toyota Memorial Hospital, Toyota, Japan","institution_ids":["https://openalex.org/I4210092859"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033814452","display_name":"K Ymamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133851","display_name":"Aichi Cancer Center","ror":"https://ror.org/03kfmm080","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Ymamoto","raw_affiliation_strings":["Department of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Cell Therapy, Aichi Cancer Center, Aichi, Japan","institution_ids":["https://openalex.org/I4210133851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113654153","display_name":"M Sawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144551","display_name":"Anjo Kosei Hospital","ror":"https://ror.org/05c06ww48","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144551"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M Sawa","raw_affiliation_strings":["Department of Hematology, Anjo Kosei Hospital, Anjo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Anjo Kosei Hospital, Anjo, Japan","institution_ids":["https://openalex.org/I4210144551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063686827","display_name":"Yuichiro Inagaki","orcid":"https://orcid.org/0009-0004-3165-4469","observed_orcids":["https://orcid.org/0009-0004-3165-4469"]},"institutions":[{"id":"https://openalex.org/I4210144551","display_name":"Anjo Kosei Hospital","ror":"https://ror.org/05c06ww48","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210144551"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y Inagaki","raw_affiliation_strings":["Department of Hematology, Anjo Kosei Hospital, Anjo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Anjo Kosei Hospital, Anjo, Japan","institution_ids":["https://openalex.org/I4210144551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017936080","display_name":"Koichi Miyamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132181","display_name":"Japanese Red Cross Nagoya Daiichi Hospital","ror":"https://ror.org/03f918r09","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210132181"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Miyamura","raw_affiliation_strings":["Department of Hematology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan","institution_ids":["https://openalex.org/I4210132181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084655190","display_name":"Takashi Naoe","orcid":"https://orcid.org/0000-0001-5300-8223","observed_orcids":["https://orcid.org/0000-0001-5300-8223"]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T Naoe","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","Dept. of Hematology and Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]},{"raw_affiliation_string":"Dept. of Hematology and Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, Japan","institution_ids":["https://openalex.org/I60134161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5069675532"],"corresponding_institution_ids":["https://openalex.org/I60134161"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":1.2267,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.80492806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"26","issue":"9","first_page":"2142","last_page":"2143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.8629999756813049},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":1.0},{"id":"https://openalex.org/keywords/cd34-hematopoietic-stem-cells","display_name":"CD34+ hematopoietic stem cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/hematopoietic-progenitor-cells","display_name":"hematopoietic progenitor cells","score":0.8019999861717224},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.7179999947547913},{"id":"https://openalex.org/keywords/abl-tyrosine-kinase-inhibitors","display_name":"ABL tyrosine kinase inhibitors","score":0.7639999985694885},{"id":"https://openalex.org/keywords/stem-cell-quiescence","display_name":"stem cell quiescence","score":0.7300000190734863},{"id":"https://openalex.org/keywords/long-term-culture-initiating-cells","display_name":"long-term culture-initiating cells","score":0.7649999856948853},{"id":"https://openalex.org/keywords/chronic-phase-cml","display_name":"chronic phase CML","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.7823308706283569},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.6858023405075073},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.6421833038330078},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5987191796302795},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.5701768398284912},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.5143967270851135},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4447927474975586},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3799549639225006},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3640420436859131},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3328555226325989},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3297210931777954},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12889164686203003},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.10381254553794861}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000359","descriptor_name":"Aftercare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018952","descriptor_name":"Antigens, CD34","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/leu.2012.73","doi":"https://doi.org/10.1038/leu.2012.73","is_oa":true,"landing_page_url":"https://doi.org/10.1038/leu.2012.73","pdf_url":"https://www.nature.com/articles/leu201273.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2440751","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3437405","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3437405","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3437405","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Text"},{"id":"pmid:22425893","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22425893","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Letter"}],"best_oa_location":{"id":"doi:10.1038/leu.2012.73","doi":"https://doi.org/10.1038/leu.2012.73","is_oa":true,"landing_page_url":"https://doi.org/10.1038/leu.2012.73","pdf_url":"https://www.nature.com/articles/leu201273.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320324144","display_name":"National Institute of Biomedical Innovation","ror":"https://ror.org/001rkbe13"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1994797642.pdf","grobid_xml":"https://content.openalex.org/works/W1994797642.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W1977310919","https://openalex.org/W1989123817","https://openalex.org/W1999404282","https://openalex.org/W2012962381","https://openalex.org/W2062166095","https://openalex.org/W2068834508","https://openalex.org/W2093616162","https://openalex.org/W2112817157","https://openalex.org/W2113835364","https://openalex.org/W2122224021","https://openalex.org/W2171532545"],"related_works":["https://openalex.org/W7097942159","https://openalex.org/W2554130121","https://openalex.org/W2574536037","https://openalex.org/W2583565525","https://openalex.org/W1999404282","https://openalex.org/W2573169346","https://openalex.org/W2980236806","https://openalex.org/W2062166095","https://openalex.org/W2979669349","https://openalex.org/W2122224021"],"abstract_inverted_index":{"ABL-tyrosine":[0,48],"kinase":[1,49],"inhibitor":[2],"(TKI),":[3],"imatinib":[4],"(IM)":[5],"is":[6],"suggested":[7],"to":[8,141],"be":[9,36],"effective":[10],"for":[11],"proliferating":[12],"leukemic":[13],"cells,":[14,99],"not":[15],"quiescent":[16],"chronic":[17],"myeloid":[18,107],"leukemia":[19],"(CML)":[20],"stem":[21,71,143],"cells.":[22,150],"1":[23],",":[24,26,102,105,124],"2":[25],"3":[27],"Recent":[28],"clinical":[29],"trials":[30],"suggest":[31],"that":[32],"CML":[33],"treatment":[34],"can":[35],"improved":[37],"with":[38,86],"more":[39,134],"potent":[40],"BCR\u2013ABL":[41,92],"inhibition":[42],"during":[43],"the":[44,61,68,131],"second":[45],"generation":[46],"of":[47,63,91,137],"inhibitors":[50],"(2nd-TKIs)":[51],"such":[52],"as":[53,147],"dasatinib":[54],"and":[55,65,74,88,112,120],"nilotinib.":[56],"4":[57],"To":[58],"comparatively":[59],"examine":[60],"effects":[62],"IM":[64],"2nd-TKIs":[66],"on":[67],"BCR\u2013ABL-positive":[69],"hematopoietic":[70],"cells":[72,138],"(HSC)":[73],"progenitors,":[75,108],"we":[76],"investigated":[77],"47":[78],"CML-chronic":[79],"phase":[80],"cases":[81],"using":[82,127],"methods":[83],"previously":[84],"reported":[85],"FACSAria":[87],"quantitative":[89],"real-time-PCR":[90],"among":[93],"each":[94],"sorted":[95],"population:":[96],"total":[97],"mononuclear":[98],"HSC/Thy-1":[100,103],"+":[101],"\u2212":[104],"common":[106],"granulocyte":[109],"macrophage":[110],"progenitors":[111,115],"megakaryocyte":[113],"erythroid":[114],"(detailed":[116],"in":[117,130],"Supplementary":[118],"Materials":[119],"Methods":[121],").":[122],"5":[123],"6":[125],"By":[126],"this":[128],"method":[129],"HSC":[132],"population,":[133],"than":[135],"30%":[136],"are":[139],"supposed":[140],"have":[142],"cell":[144],"potential,":[145],"probably":[146],"long-term":[148],"culture-initiating":[149],"7":[151]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}